Please try another search
BERWYN, Pa. - Virpax Pharmaceuticals Inc. (NASDAQ: VRPX) has announced favorable outcomes from a Maximum Tolerated Dose (MTD) study for its drug Probudur, a non-addictive pain...
BERWYN, Pa. - Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX), a company focused on developing non-addictive therapies for pain and other central nervous system disorders, has...
Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder,...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Sell | Sell | Sell | Strong Sell | Strong Sell |
Technical Indicators | Sell | Sell | Strong Sell | Strong Sell | Strong Sell |
Summary | Sell | Sell | Strong Sell | Strong Sell | Strong Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Completed Patterns | |||||
Bullish doji Star | 5H | 6 | Apr 25, 2024 20:00 | ||
Homing Pigeon | 30 | 7 | Apr 29, 2024 21:30 | ||
Abandoned Baby Bullish | 15 | 8 | Apr 29, 2024 21:45 | ||
Morning Doji Star | 15 | 8 | Apr 29, 2024 21:45 | ||
Bullish doji Star | 15 | 9 | Apr 29, 2024 21:15 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
Zenith Bank | 32.05 | 32.30 | 32.00 | +0.80 | +2.56% | 11.77M | 14:30:00 | ||
Access Holdings | 16.80 | 17.25 | 16.85 | -0.10 | -0.59% | 42.65M | 14:30:00 | ||
Guaranty Trust Holding | 32.70 | 32.85 | 32.35 | 0.00 | 0.00% | 245.46M | 14:30:00 | ||
Transcorp | 14.000 | 14.000 | 13.750 | 0.000 | 0.00% | 36.08M | 14:30:00 | ||
UBA | 23.90 | 24.70 | 23.30 | +0.65 | +2.80% | 22.45M | 14:30:00 | ||
FBN Holdings | 23.70 | 24.50 | 22.95 | +1.55 | +6.94% | 44.83M | |||
Dangote Sugar | 39.00 | 40.00 | 38.90 | -4.30 | -9.95% | 17.73M | 14:30:00 | ||
UAC Of Nigeria | 14.85 | 14.85 | 13.70 | +1.35 | +10.00% | 2.21M | 14:17:00 | ||
Conoil | 92.50 | 99.95 | 99.95 | +9.05 | +9.96% | 482.88K | |||
Maybaker | 6.100 | 6.100 | 6.100 | +0.100 | +1.67% | 184.67K | 14:16:00 |
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical spray film delivery technology for osteoarthritis pain; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company’s preclinical stage product candidates also comprise AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and NobrXiol, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review